After 4 h of co-incubation, CD8+ T cells previously exposed to melphalan-treated melanoma cells showed a significantly higher degree of degranulation, as reflected by higher CD107a expression, toward melanoma target cells (Figure 4H). The gene discussed is CD8A; the disease is melanoma.